Fund holdings
535KShares reported
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Loading…
TECH · NASDAQ · Life Sciences Tools & Services
Life Sciences Tools & Services company based in Minneapolis, Minnesota.
Last close, Oct 1, 2026
$72.40
Adjusted for splits and dividends
Last 12 months
+20.8%
S&P 500 +14.3% over the same dates
Market value
$11.4B
Last close × shares outstanding
Bets against the stock: 6.63M shares sold short (4.2% of shares outstanding), +12.5% vs the previous count, 2.7 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2026
$1.22B
-0.4% vs the year before
Net income, fiscal 2025
$73.4M
As reported in the annual filing
Shares outstanding
157M
As of Aug 17, 2026
In fiscal 2026 the company spent $41.7M buying back its own shares and $49.9M on dividends. Cash actually paid, from its cash-flow statement.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Stock since the trade +49.7% · S&P 500 +3.6% · to Oct 1Traded 2 days after resultsStock within 4% of its 52-week low
6,836 → 200 shares held−97% of their stake
A board member of Bio-Techne sold $320K of Bio-Techne shares. Nobody planned it ahead of time.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Held by the filer's dependent child per the disclosure. Disclosed 28 days after the transaction; reported as an official range, not an exact amount.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 25.2% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 43.4%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
FMR LLC
Schedule 13G: passive · filed Aug 6, 2026 · 12.8M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 29, 2026 · 11.6M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Last 12 months, adjusted daily closes
Adjusted close went from $59.92 on Oct 1, 2025 to $72.40 on Oct 1, 2026 (+20.8%). Disclosed trades in the last 12 months: 0 insider purchases, 2 insider sales, 3 Congress purchases, 4 Congress sales.
Congress trade